Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Open Studies | "Giant Cell Arteritis"
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone;   Drug: Placebo to match prednisone
2 Recruiting Biomarkers in Giant Cells Arteritis
Condition: Giant Cells Arteritis
Interventions: Behavioral: Clinical evaluation;   Other: Paraclinical evaluation;   Device: Imaging;   Other: Ophthalmologic examination;   Biological: Dosage of biomarkers
3 Not yet recruiting Giant Cell Arteritis and Anakinra Trial
Condition: Giant Cell Arteritis
Interventions: Drug: PLACEBO;   Drug: ANAKINRA
4 Not yet recruiting Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
Condition: Giant Cell Arteritis
Intervention: Device: Ultrasound of temporal and axillary arteries
5 Recruiting Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
6 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
7 Recruiting Study of Circulating Microparticles in Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Acute Phase
Intervention: Other: Blood sample
8 Not yet recruiting Ustekinumab for the Treatment of Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Temporal Arteritis;   Horton's Disease
Interventions: Drug: Ustekinumab;   Drug: Prednisone
9 Recruiting Validation of a Diagnostic Algorithm of Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Other: color Doppler ultrasound and TAB in case of CDU negative
10 Not yet recruiting Aetiology of TemporaL Arteritis Study
Condition: Temporal Arteritis
Intervention:
11 Recruiting Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease
Condition: Horton's Disease
Intervention: Biological: Blood samples
12 Not yet recruiting Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE
Condition: Polymyalgia Rheumatica
Interventions: Drug: Tocilizumab;   Drug: Placebo
13 Not yet recruiting Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone /Prednisone placebo
14 Recruiting Improving the Diagnosis and Prognostication of GCA Through the Novel Use of PET Scan and Immune Biomarkers
Condition: Giant Cell Arteritis
Intervention:
15 Recruiting Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease
Condition: Horton Disease
Interventions: Radiation: Vascular tomodensitometry;   Other: Magnetic resonance angiography;   Other: Vascular ultrasonography;   Other: Retinal angiography;   Other: Retinal optical coherence tomography
16 Recruiting Delayed Release Prednisone in PMR
Condition: Polymyalgia Rheumatica
Interventions: Drug: Delayed-Release (DR) Prednisone;   Drug: Immediate Release (IR) Prednisone
17 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
18 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
19 Recruiting VCRC Tissue Repository
Conditions: Aortitis;   Cutaneous Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis;   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Henoch-Schonlein Purpura;   IgA Vasculitis;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu Arteritis;   Churg-Strauss Syndrome
Intervention:

Study has passed its completion date and status has not been verified in more than two years.